The selective killing effect of adenoviral mediated HSV-tk/GCV suicide gene system controlled by hTERT promoter on bladder cancer cells

被引:0
|
作者
王亚轩
机构
[1] Shijiazhuang 050000
[2] 2nd Hos
[3] Dept Urol
[4] Hebei Med Univ
关键词
D O I
暂无
中图分类号
R737.14 [膀胱肿瘤];
学科分类号
100214 ;
摘要
To investigate the selective killing effect of adenoviral mediated herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system controlled by human telomerase reverse transcriptase (hTERT) promoter on bladder cancer cells in vitro.Methods Bladder cancer cell line 253J and human fibroblast cell line MRC-5 were transfected by the recombinant adenovirus of different multiplicities of infection (MOI),and the infection rate was measured by observing the expression of enhanced green fluorescent protein (EGFP) under the fluorescent microscopy.Ad-hTERT-HSV/tk and Ad-CMV-SHV/tk were transduced into 253J and MRC-5,followed by GCV treatment.The relative survival rate of cells in presence of prodrug GCV was measured with MTT method.Results Recombinant adenovirus Ad-hTERT-EGFP could selectively infect 253J cells,with the infection rate associated with the increasing MOI of recombinant adenovirus (P<0.01).When MOI was 1,the infection rate was 8.3%;when MOI was 1000,the infection rate was 100.0%.GCV significantly inhibited the growth of both cell lines (253J and MRC-5) infected with Ad-CMV-HSV/tk and the growth of only 253J infected with Ad-hTERT-HSV/tk (P<0.001).The survival rate of 253J was correlated with the concentration of both the prodrugs and MOI of recombinant adenovirus (P<0.01).When MOI was 1,with 1 μmol/L GCV,the survival rate of 253J was 95.4%;when MOI was 100,with 1000 μmol/L GCV,the survival rate of 253J was 6.1%.Conclusion Recombinant adenovirus vector containing EGFP can report the transfection rate accurately and easily.Adenoviral vector containing hTERT promoter for the HSV/tk plus GCV treatment appears to be highly selective in killing bladder cancer cell line in vitro.7 refs.2 tabs.
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [21] USE OF ADENOVIRAL MEDIATED GENE-TRANSFER OF HSV-TK IN AN ASCITES MODEL OF BREAST-CANCER
    YEE, D
    MCGUIRE, SE
    CHEN, SH
    HILSENBECK, SG
    BRUNNER, N
    WOO, SLC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 430 - 430
  • [22] HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
    Yang Lifang
    Tang Min
    Ai Midan
    Cao Ya
    Journal of Experimental & Clinical Cancer Research, 27
  • [23] Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population
    Weiwei Hu
    Weiguo Liu
    In Vitro Cellular & Developmental Biology - Animal, 2010, 46 : 497 - 501
  • [24] Interleukin-2 enhanced the anti-tumor effect of adenoviral-mediated HSV-tk gene therapy in a murine bladder cancer model
    Terao, S
    Sirakawa, T
    Hinata, N
    Kamidono, S
    Gotoh, A
    MOLECULAR THERAPY, 2004, 9 : S226 - S226
  • [25] Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population
    Hu, Weiwei
    Liu, Weiguo
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2010, 46 (06) : 497 - 501
  • [26] Enhanced killing of glioblastoma cells by HSV-1 vector mediated combined IκBα mutant and HSV-TK expression under GCV administration
    Moriuchi, S
    Yamasaki, M
    Yoshimine, T
    Wolf, D
    Huang, SH
    Cohen, J
    Glorioso, JC
    MOLECULAR THERAPY, 2003, 7 (05) : S286 - S287
  • [27] The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells
    Zeng, Zhao-Jun
    Xiang, Sheng-Guang
    Xue, Wei-Wen
    Li, Hong-De
    Ma, Nan
    Ren, Zi-Jing
    Xu, Zhu-Jun
    Jiao, Chun-Hong
    Wang, Cui-Yun
    Hu, Wei-Xin
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (07) : 887 - 892
  • [28] Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer
    Tang, Qiusha
    Zhang, Dongsheng
    Wan, Meilin
    Jin, Liqiang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (06) : 755 - 761
  • [29] Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy
    Nasu, Yasutomo
    Saika, Takashi
    Ebara, Shin
    Kusaka, Nobuyuki
    Kaku, Haruki
    Abarzua, Fernando
    Manabe, Daisuke
    Thompson, Timothy C.
    Kumon, Hiromi
    MOLECULAR THERAPY, 2007, 15 (04) : 834 - 840
  • [30] Enhanced Cell Killing Effect of E1 Modified Adenoviruses Expressing HSV-TK Suicide Gene
    Kwon, Oh-Joon
    Ko, Dong Hyun
    Huang, Jing Hwa
    Choi, Il-Kyu
    Jung, Sung-Mi
    Kim, Joo-Hang
    Cho, Byoung Chul
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2006, 13 : S56 - S56